Literature DB >> 19637156

The relevance of polar surface area (PSA) in rationalizing biological properties of several cis-diamminemalonatoplatinum(II) derivatives.

Giulia Caron1, Giuseppe Ermondi, Marzia B Gariboldi, Elena Monti, Elisabetta Gabano, Mauro Ravera, Domenico Osella.   

Abstract

A panel of six cis-diamminemalonatoplatinum(II) derivatives were designed and synthesized, and their physicochemical properties and in vitro biological activity were experimentally evaluated and studied in silico. All the complexes showed higher IC(50) values (> or =20 microM) than those observed for cisplatin and its malonato analogue on three different human tumor cell lines, namely A2780 ovarian carcinoma, A549 lung carcinoma, and MCF-7 breast carcinoma. In silico studies revealed that polar surface area (PSA) is the best descriptor to explain the poor biological activity observed for this series of new compounds, which in turn is likely due to poor cellular uptake. This finding is in line with general rules that assign a major role to PSA in characterizing the transport properties of drugs, in the actual case of antiproliferative metallopharmaceuticals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19637156     DOI: 10.1002/cmdc.200900224

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  3 in total

1.  Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling.

Authors:  Paola Gramatica; Ester Papa; Mara Luini; Elena Monti; Marzia B Gariboldi; Mauro Ravera; Elisabetta Gabano; Luca Gaviglio; Domenico Osella
Journal:  J Biol Inorg Chem       Date:  2010-06-06       Impact factor: 3.358

2.  Molecular interaction fields (MIFs) to predict lipophilicity and ADME profile of antitumor Pt(II) complexes.

Authors:  Giulia Caron; Mauro Ravera; Giuseppe Ermondi
Journal:  Pharm Res       Date:  2010-11-17       Impact factor: 4.200

3.  Low-Dose Near-Infrared Light-Activated Mitochondria-Targeting Photosensitizers for PDT Cancer Therapy.

Authors:  Wenyu Wu Klingler; Nadine Giger; Lukas Schneider; Vipin Babu; Christiane König; Patrick Spielmann; Roland H Wenger; Stefano Ferrari; Bernhard Spingler
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.